Tyrosine kinase inhibitors. 18. 6-Substituted 4-anilinoquinazolines and 4-anilinopyrido[3,4-d]pyrimidines as soluble, irreversible inhibitors of the epidermal growth factor receptor
- PMID: 11462982
- DOI: 10.1021/jm000372i
Tyrosine kinase inhibitors. 18. 6-Substituted 4-anilinoquinazolines and 4-anilinopyrido[3,4-d]pyrimidines as soluble, irreversible inhibitors of the epidermal growth factor receptor
Abstract
4-Anilinoquinazoline- and 4-anilinopyrido[3,4-d]pyrimidine-6-acrylamides are potent pan-erbB tyrosine kinase inactivators, and one example (CI-1033) is in clinical trial. A series of analogues with a variety of Michael acceptor units at the 6-position were prepared to define the structural requirements for irreversible inhibition. A particular goal was to determine whether additional functions to increase solubility could be appended to the Michael acceptor. Substituted acrylamides were prepared by direct acylation of the corresponding 6-amines with the requisite acid or acid chloride. Vinylsulfonamide derivatives were obtained by acylation of the amines with chloroethylsulfonyl chloride followed by base-promoted elimination. Vinylsulfone and vinylsulfine derivatives were prepared by oxidation and base elimination of a hydroxyethylthio intermediate. The compounds were evaluated for their inhibition of phosphorylation of the isolated EGFR enzyme and for inhibition of EGF-stimulated autophosphorylation of EGFR in A431 cells and of heregulin-stimulated autophosphorylation of erbB2 in MDA-MB 453 cells. Substitution at the nitrogen of the acrylamide was tolerated only with a methyl group; larger substituents were dystherapeutic, and no substitution at all was tolerated at the acrylamide alpha-carbon. In contrast, while electron-donating groups at the acrylamide beta-carbon were not useful, even quite large electron-withdrawing groups (which increase its electrophilicity) were tolerated. A series of derivatives with solubility-enhancing substituents linked to the acrylamide beta-carbon via amides were potent irreversible inhibitors of isolated EGFR (IC50s = 0.4-1.1 nM), with weakly basic morpholine and imidazole derivatives being the best. Vinylsulfonamides were also potent and irreversible inhibitors, but vinylsulfones and vinylsulfines were reversible and only poorly active. Two compounds were evaluated against A431, H125, and MCF-7 xenografts in nude mice but were inferior in these assays to the clinical trial compound CI-1033.
Similar articles
-
Tyrosine kinase inhibitors. 17. Irreversible inhibitors of the epidermal growth factor receptor: 4-(phenylamino)quinazoline- and 4-(phenylamino)pyrido[3,2-d]pyrimidine-6-acrylamides bearing additional solubilizing functions.J Med Chem. 2000 Apr 6;43(7):1380-97. doi: 10.1021/jm990482t. J Med Chem. 2000. PMID: 10753475
-
Tyrosine kinase inhibitors. 15. 4-(Phenylamino)quinazoline and 4-(phenylamino)pyrido[d]pyrimidine acrylamides as irreversible inhibitors of the ATP binding site of the epidermal growth factor receptor.J Med Chem. 1999 May 20;42(10):1803-15. doi: 10.1021/jm9806603. J Med Chem. 1999. PMID: 10346932
-
6-Substituted-4-(3-bromophenylamino)quinazolines as putative irreversible inhibitors of the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor (HER-2) tyrosine kinases with enhanced antitumor activity.J Med Chem. 2001 Aug 16;44(17):2719-34. doi: 10.1021/jm0005555. J Med Chem. 2001. PMID: 11495584
-
Specific inhibition of epidermal growth factor receptor tyrosine kinase by 4-anilinoquinazolines.Breast Cancer Res Treat. 1996;38(1):67-73. doi: 10.1007/BF01803785. Breast Cancer Res Treat. 1996. PMID: 8825124 Review.
-
4-Anilinoquinazoline Derivatives with Epidermal Growth Factor Receptor Inhibitor Activity.Anticancer Agents Med Chem. 2016;16(12):1652-1664. doi: 10.2174/1871520616666160404113141. Anticancer Agents Med Chem. 2016. PMID: 27039919 Review.
Cited by
-
Clinical development of targeted and immune based anti-cancer therapies.J Exp Clin Cancer Res. 2019 Apr 11;38(1):156. doi: 10.1186/s13046-019-1094-2. J Exp Clin Cancer Res. 2019. PMID: 30975211 Free PMC article. Review.
-
Identification of an Allene Warhead That Selectively Targets a Histidine Residue in the Escherichia coli Oxidoreductase Enzyme DsbA.ACS Med Chem Lett. 2025 Mar 22;16(4):625-630. doi: 10.1021/acsmedchemlett.5c00016. eCollection 2025 Apr 10. ACS Med Chem Lett. 2025. PMID: 40236539
-
Small molecule tyrosine kinase inhibitors of ErbB2/HER2/Neu in the treatment of aggressive breast cancer.Molecules. 2014 Sep 23;19(9):15196-212. doi: 10.3390/molecules190915196. Molecules. 2014. PMID: 25251190 Free PMC article. Review.
-
Imaging of EGFR and EGFR tyrosine kinase overexpression in tumors by nuclear medicine modalities.Curr Pharm Des. 2008;14(28):2983-98. doi: 10.2174/138161208786404326. Curr Pharm Des. 2008. PMID: 18991714 Free PMC article. Review.
-
Molecular imaging of EGFR kinase activity in tumors with 124I-labeled small molecular tracer and positron emission tomography.Mol Imaging Biol. 2006 Sep-Oct;8(5):262-77. doi: 10.1007/s11307-006-0049-0. Mol Imaging Biol. 2006. PMID: 16897320
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Chemical Information
Research Materials
Miscellaneous